Executives On The Move: BioMarin Pharma Selects Technology And Operations Head, Celgene CFO Makes A Switch And Sangamo Welcomes CBO
BioMarin Pharmaceutical selects a new CTO and EVP of Manufacturing and Ops, and Swiss oncology biotech ADC Therapeutics hires a former Celgene CFO. Plus, genomic medicines firm Sangamo Therapeutics welcomes a CBO to oversee commercialization strategies.
You may also be interested in...
Executives On The Move: Exits At Allergan And Sanofi, And Wave Life Sciences Fills Newly Created Position
Artax Biopharma, focusing on autoimmune diseases, selects Sanofi Genzyme R&D SVP as its new CMO, and Allergan chief information officer accepts same post at Merck spin off Organon & Co. Also, genetic medicines company Wave Life Sciences fills newly created position of SVP of therapeutics discovery.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Executives On The Move: New Choices For Finance Spots At Merz Aesthetics, Spruce Biosciences And Lodo Therapeutics
New CFOs are announced at three companies: MerzPharma Group’s Merz Aesthetics; Spruce Biosciences, a firm focusing on treatments for rare endocrine disorders; and Lodo Therapeutics, which is developing novel therapeutics for undruggable targets.